Goutham Narla
Fondateur chez Rappta Therapeutics Oy
Profil
Goutham Narla is the Chief Scientific Officer and founder of Rappta Therapeutics Oy, which is founded in 2019.
Dr. Narla is also the founder of Dual Therapeutics LLC.
Postes actifs de Goutham Narla
| Sociétés | Poste | Début |
|---|---|---|
Rappta Therapeutics Oy
 Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Fondateur | 20/03/2019 |
Anciens postes connus de Goutham Narla
| Sociétés | Poste | Fin |
|---|---|---|
Dual Therapeutics LLC
 Dual Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Dual Therapeutics LLC develops novel therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. The company was founded in 2013 and is headquartered in Cleveland, OH. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Rappta Therapeutics Oy
Rappta Therapeutics Oy BiotechnologyHealth Technology Rappta Therapeutics Oy operates as a biopharmaceutical company. It develops anti-cancer drugs activating protein phosphatase 2A. The company was founded by Goutham Narla and Mikko Lauri Sampsa Mannerkoski on March 20, 2019 and is headquartered in Helsinki, Finland. | Health Technology |
Dual Therapeutics LLC
Dual Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Dual Therapeutics LLC develops novel therapeutics for prostate cancer, lung cancer, and acute lymphoblastic leukemia. The company was founded in 2013 and is headquartered in Cleveland, OH. | Commercial Services |